Nathan Rice Stock Analyst Profile - Piper Sandler Research Coverage - Stocknear

Nathan Rice

Stock Analyst at Piper Sandler

(4.42)
# 1568
Out of 5,474 analysts
63
Total ratings
Success rate
Average return
16 Stocks
Name Action PT Current % Upside Ratings Updated
MBIN Merchants Bancorp
Maintains: Overweight
42 41
31.79 28.97% 8 Jul 30, 2025
FMBH First Mid Bancshares
Maintains: Overweight
47 49
39.78 23.18% 4 Jul 28, 2025
BFC Bank First
Maintains: Neutral
115 137
128.35 6.74% 8 Jul 21, 2025
BY Byline Bancorp
Reiterates: Overweight
34 34
28.9 17.65% 8 Oct 29, 2024
CVS CVS Health
Maintains: Buy
85 74
71.75 3.14% 2 May 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Neutral
84
135.32 -37.92% 1 Jan 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
197
135.93 44.93% 8 Dec 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
11 9
18.77 -52.05% 1 Apr 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
40
16.35 144.65% 1 Dec 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
530 435
655.6 -33.65% 4 Jul 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
233
302.12 -22.88% 3 Dec 14, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
83
31.11 166.8% 4 Dec 14, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
15
18.26 -17.85% 1 Dec 19, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
49 54
n/a n/a 4 Feb 8, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
30 31
21.51 44.12% 2 Jul 27, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 4 Jul 24, 2017